Sean Moran

Insider Reports History

Location
Norwood, MA
Signature
/s/ Sean Moran
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sean Moran:

Company Role Class Num Shares Value Price $ Report Date Ownership
Corbus Pharmaceuticals Holdings, Inc. Chief Financial Officer Common Stock, par value $0.0001 per share 96,694 $752,569 $7.78 13 Feb 2026 Direct
Corbus Pharmaceuticals Holdings, Inc. Chief Financial Officer Stock options (right to buy) 84,247 14 Jan 2026 Direct

Insider Reports Filed by Sean Moran

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRBP Corbus Pharmaceuticals Holdings, Inc. 13 Feb 2026 1 -$36,588 4 Chief Financial Officer 18 Feb 2026, 16:31
CRBP Corbus Pharmaceuticals Holdings, Inc. 14 Jan 2026 2 $0 4 Chief Financial Officer 16 Jan 2026, 16:30
CRBP Corbus Pharmaceuticals Holdings, Inc. 24 Oct 2025 3 -$165,638 4 Chief Financial Officer 27 Oct 2025, 16:22
CRBP Corbus Pharmaceuticals Holdings, Inc. 14 Feb 2025 1 -$24,446 4 Chief Financial Officer 18 Feb 2025, 17:40
CRBP Corbus Pharmaceuticals Holdings, Inc. 31 Jan 2025 2 $0 4 Chief Financial Officer 04 Feb 2025, 17:13
CRBP Corbus Pharmaceuticals Holdings, Inc. 14 Jun 2024 12 -$630,018 4 Chief Financial Officer 18 Jun 2024, 17:59
CRBP Corbus Pharmaceuticals Holdings, Inc. 10 Apr 2024 2 +$53,610 4 Chief Financial Officer 11 Apr 2024, 09:17
CRBP Corbus Pharmaceuticals Holdings, Inc. 12 Feb 2024 2 $0 4 Chief Financial Officer 14 Feb 2024, 15:26
CRBP Corbus Pharmaceuticals Holdings, Inc. 13 Feb 2023 1 $0 4 Chief Financial Officer 15 Feb 2023, 11:51
CRBP Corbus Pharmaceuticals Holdings, Inc. 10 Aug 2022 1 +$5,198 4 Chief Financial Officer 10 Aug 2022, 10:16
CRBP Corbus Pharmaceuticals Holdings, Inc. 16 May 2022 1 +$3,600 4 Chief Financial Officer 16 May 2022, 11:03
CRBP Corbus Pharmaceuticals Holdings, Inc. 10 Mar 2022 1 +$5,550 4 Chief Financial Officer 10 Mar 2022, 10:47
CRBP Corbus Pharmaceuticals Holdings, Inc. 01 Feb 2022 1 $0 4 Chief Financial Officer 02 Feb 2022, 16:46